Seroatlas · Human Serome Atlas

FH

Fumarate hydratase, mitochondrial

Also known as: FUMH_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P07954
Gene
FH
Ensembl
ENSG00000091483
Chromosome
1
Canonical length
510 aa
Protein class
Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homotetramer

OverviewNCBI Gene

The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

510 residues, UniProt reviewed canonical sequence.

>P07954|FH
     1  MYRALRLLAR SRPLVRAPAA ALASAPGLGG AAVPSFWPPN AARMASQNSF RIEYDTFGEL
    61  KVPNDKYYGA QTVRSTMNFK IGGVTERMPT PVIKAFGILK RAAAEVNQDY GLDPKIANAI
   121  MKAADEVAEG KLNDHFPLVV WQTGSGTQTN MNVNEVISNR AIEMLGGELG SKIPVHPNDH
   181  VNKSQSSNDT FPTAMHIAAA IEVHEVLLPG LQKLHDALDA KSKEFAQIIK IGRTHTQDAV
   241  PLTLGQEFSG YVQQVKYAMT RIKAAMPRIY ELAAGGTAVG TGLNTRIGFA EKVAAKVAAL
   301  TGLPFVTAPN KFEALAAHDA LVELSGAMNT TACSLMKIAN DIRFLGSGPR SGLGELILPE
   361  NEPGSSIMPG KVNPTQCEAM TMVAAQVMGN HVAVTVGGSN GHFELNVFKP MMIKNVLHSA
   421  RLLGDASVSF TENCVVGIQA NTERINKLMN ESLMLVTALN PHIGYDKAAK IAKTAHKNGS
   481  TLKETAIELG YLTAEQFDEW VKPKDMLGPK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
253 nTPM

Expression across tissuesHPA

Tissue

  • liver: 253 nTPM
  • tongue: 213 nTPM
  • skeletal muscle: 197 nTPM
  • heart muscle: 166 nTPM
  • kidney: 93 nTPM
  • parathyroid gland: 88 nTPM

Single-cell type

  • late primary spermatocytes: 208 nCPM
  • syncytiotrophoblasts: 200 nCPM
  • early spermatids: 197 nCPM
  • esophageal basal cells: 128 nCPM
  • cytotrophoblasts: 125 nCPM
  • oocytes: 115 nCPM

Immune cell

  • myeloid DC: 45 nTPM
  • intermediate monocyte: 31 nTPM
  • non-classical monocyte: 28 nTPM
  • memory B-cell: 27 nTPM
  • naive B-cell: 25 nTPM
  • T-reg: 23 nTPM

Brain region

  • choroid plexus: 50 nTPM
  • cerebral cortex: 28 nTPM
  • hypothalamus: 27 nTPM
  • cerebellum: 27 nTPM
  • white matter: 26 nTPM
  • spinal cord: 26 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FH.

Disease | AllUniProt

Conditions FH is implicated in, by any mechanism.

Disease | GeneticClinVar

501 pathogenic / likely-pathogenic of 2,515 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | ImmuneIEDB

Conditions an epitope on FH was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.54
gnomAD pLI
0.09
gnomAD missense Z
1.27
DepMap mean gene effect
-0.21
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FH as an antibody target. Whether an autoantibody or antibody against FH could matter depends on whether native FH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FH. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...